Jan 18, 2022 7:00am EST ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Recruitment of Dr. Carsten Korth to its Scientific Advisory Board
Jan 07, 2022 7:00am EST ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer’s Treatment
Jan 06, 2022 7:30am EST ProMIS Neurosciences to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference
Nov 17, 2021 7:00am EST A Second Independent Proxy Advisor, ISS, Recommends ProMIS Neurosciences Shareholders Vote for the Share Consolidation
Nov 02, 2021 7:00am EDT Glass Lewis Recommends ProMIS Neurosciences Shareholders Vote for the Share Consolidation at the Upcoming Special Meeting
Oct 22, 2021 7:00am EDT ProMIS Neurosciences Appoints Accomplished Biotech Executive, Dr. Maggie Shafmaster, to its Board of Directors